ニューヨークにおける移植片対宿主病の臨床試験
ニューヨーク内の拠点で、移植片対宿主病に関する10件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
- Roswell Park Comprehensive Cancer Center, Buffalo
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT06450925A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07359859Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07216443A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- New York University (Data Collection Only), New York
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07006506Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
- Northwell Health, New Hyde Park
被験者募集中第1/2相
14歳〜100歳 · 全性別 · 2026/05/29更新 · NCT05289167A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
- Memorial Sloan Kettering Cancer Center @ Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第2相
4歳以上 · 全性別 · 2026/05/22更新 · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/20更新 · NCT06615050Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
被験者募集中第2相
26歳以下 · 全性別 · 2026/05/14更新 · NCT07566377Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- University of Rochester, Rochester
被験者募集中第2相
2歳以上 · 全性別 · 2026/05/11更新 · NCT04380740Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2025/04/15更新 · NCT06462365ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。